![[Sweetch in Unite.AI] Dr. Yossi Bahagon, Co-Founder & Chairman of Sweetch – Interview Series](https://blog.ourcrowd.com/wp-content/uploads/2021/08/unite.png)
Dr. Yossi Bahagon, is the Co-Founder & Chairman of Sweetch an Artificial Intelligence based platform for large scale prediction, prevention, management and outcome improvement of chronic disease. Read more...
Read More![[Sweetch in TechCrunch] Sweetch raises $20M for a personalized engagement system designed to boost health outcomes](https://blog.ourcrowd.com/wp-content/uploads/2017/09/Techcrunch.jpg)
You’ve just sat down to dinner and your wearable device reminds you to get up and get in your steps for the day. Maybe the app has a point, but odds are you’ll push the notification to the side. The founders of Sweetch, an Israeli company creating its own AI-driven behavior change app, are betting that if you got that notification in a different way, you’ll be more likely to take its advice. Read more...
Read More![[Sweetch in NoCamels] OurCrowd’s Jon Medved: Pandemic Dramatically Accelerating Already Existing Tech Trends](https://blog.ourcrowd.com/wp-content/uploads/2017/10/nocamels-NEW.jpg)
Some of these things we were all doing already in some form or another, says Jon Medved, founder and CEO of OurCrowd, Israel’s most active venture investor and crowdfunding platform, “and this crisis is accelerating trends that were already present.” Read...
Read More![[Sweetch in Israel21c] 30 Israeli medical innovations to fight coronavirus](https://blog.ourcrowd.com/wp-content/uploads/2018/02/israel-21cNEW.jpg)
Whether it’s in diagnostics, treatment or care management, Israel’s innovators are busy inventing and adapting technologies to ease the coronavirus burden on the world. Read...
Read More![[Sweetch in CBN] Meet the Israeli Tech Companies Fighting COVID-19 Head-On](https://blog.ourcrowd.com/wp-content/uploads/2018/04/cbn-news.png)
OurCrowd, a leading Jerusalem-based investment platform, says several of its portfolio companies are helping save lives. Read...
Read More
